Curiox Biosystems Co., Ltd (KOSDAQ:445680)
South Korea
· Delayed Price · Currency is KRW 93,700
-16,600 (-15.05%)
At close: Mar 9, 2026
Curiox Biosystems Revenue
Curiox Biosystems had revenue of 1.38B KRW in the quarter ending September 30, 2025, with 45.53% growth. This brings the company's revenue in the last twelve months to 4.26B, down -28.63% year-over-year. In the year 2024, Curiox Biosystems had annual revenue of 4.59B, down -32.41%.
Revenue (ttm)
4.26B
Revenue Growth
-28.63%
P/S Ratio
376.72
Revenue / Employee
n/a
Employees
n/a
Market Cap
1,604.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.59B | -2.20B | -32.41% |
| Dec 31, 2023 | 6.79B | -449.07M | -6.21% |
| Dec 31, 2022 | 7.24B | 1.71B | 31.04% |
| Dec 31, 2021 | 5.52B | 1.14B | 25.97% |
| Dec 31, 2020 | 4.38B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Livsmed | 44.16B |
| Biodyne | 4.98B |
| M.I.TECH Co.,Ltd | 40.20B |
| Synergy Innovation | 106.25B |
| BIOBIJOU | 33.71B |
| Corentec | 106.14B |
| DENTIS CO.,Ltd | 117.11B |
| Celemics | 6.13B |